Senior insider sale
Chief Development Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$6.56M
80K shares
What this filing means
GUYER WILLIAM plans to sell 80K shares of CORCEPT THERAPEUTICS INC valued at approximately $6.56M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2026ACC: 0001973251-26-000030
Officer· Chief Development Officer
Since Aug 2021
80K
Shares to sell
$6.56M
Approx. market value
20K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/4/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/4/2026 | Stock Option Exercise Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
20K
Market value
$1.86M
7/7/2026
—Completed
Units to sell
20K
Market value
$1.41M
6/2/2026
—Completed
Units to sell
20K
Market value
$1.04M
5/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$2.26M
8/4/2026
Total
Units
80K
Value
$6.56M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/7/2026 | 20K | $1.86M | — | Completed |
6/2/2026 | 20K | $1.41M | — | Completed |
5/5/2026 | 20K | $1.04M | — | Completed |
| Planned — Approximate Date | ||||
8/4/2026 | 20K | $2.26M | NASDAQ | Planned |
| Total | 80K | $6.56M | ||